Clinical Trial Update: Empagliflozin as a Potential Therapeutic Solution for Patients With Brugada Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating empagliflozin as a potential therapy for Brugada syndrome; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brugada Syndrome

Drugs mentioned

• Jardiance (empagliflozin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Brugada Syndrome (BrS) | Phase 2 | Status: NOT_YET_RECRUITING